The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Dendreon; Genomic Health; Myriad Pharmaceuticals; Sanofi
Consulting or Advisory Role - Dendreon; Genomic Health; Myriad Pharmaceuticals; Sanofi

Antigen-specific immune responses through 24 months in the STAND trial: A randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (sip-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC).
 
Emmanuel S. Antonarakis
Honoraria - Dendreon; Medivation; Sanofi
Consulting or Advisory Role - Dendreon; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Adam S. Kibel
No Relationships to Disclose
 
George W. Adams
Consulting or Advisory Role - Cardinal Health
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medicale; Swan Valley Medicale (I)
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Research Funding - Argos Therapeutics (Inst); Astellas Pharma (Inst); BN ImmunoTherapeutics (Inst); Dendreon (Inst); Janssen (Inst)
 
Aymen Elfiky
No Relationships to Disclose
 
Neal D. Shore
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium/Prometrika; Pfizer; Sanofi
Research Funding - Carolina Urologic Research Center
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium/Prometrika; Pfizer; Sanofi
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Janssen Biotech
Speakers' Bureau - Bayer; Caris MPI; Dendreon; GlaxoSmithKline; Medivation; Millennium; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
John M. Corman
Research Funding - Dendreon
 
Robert Claude Tyler
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
Travel, Accommodations, Expenses - Dendreon
Other Relationship - Dendreon
 
Candice McCoy
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Todd DeVries
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
Consulting or Advisory Role - KinDex
 
Nadeem A. Sheikh
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; ImmuneXcite
Consulting or Advisory Role - Bristol-Myers Squibb; Compugen; Dendreon; ImmuneXcite; Janssen; Pfizer; Roche
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Janssen